2013 as 10.1200/JCO.2013.50.9984 The latest version is at /cgi/doi/10.1200/JCO.2013.50.9984 JOURNAL OF CLINICAL ONCOLOGY A S C O S P E C I A L A R T I C L E Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology...
The American Society of Clinical Oncology (ASCO) has updated its recommendations regarding the use of pharmacological agents for breast cancer risk reduction. The new guidelines were developed by an expert panel after a review of the literature that identified relevant randomised trials published since ...
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual. ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice...
参考文献 [1] Endocrine Treatment and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer Guideline and Rapid Update https://old-prod.asco.org/practice-patients/guidelines/breast-cancer#/9326 [2] Biomarkers for Systemic Therapy in Metastatic Breast Cancer Guideline and Rapid Upda...
[2] Biomarkers for Systemic Therapy in Metastatic Breast Cancer Guideline and Rapid Update https://old-prod.asco.org/practice-patients/guidelines/breast-cancer#/9676 推荐阅读: 1.一文了解:癌症之王~胰腺癌 2.攻坚肺癌EGFR耐药,第四...
Xu Jiaojiao, Chen Zhanhong, Wang Xiaojia. Current progress and advances in breast cancer: Highlights from 2023 ASCO annual meeting. Journal of Practical Oncology, 2023, 38(4): 317-323. 2023年美国临床肿瘤学会(American Society of Clinical Oncology, ASCO)年会于...
2020ASCO卵巢癌PARP抑制剂指南重磅公布！海量临床数据直击五大临床问题！
[3]NCCN clinical practice guidelines in oncology(NCCN Guidelines®);Breast Cancer,Version 1.2023—January 27,2024 [4]乳腺癌诊疗指南(2024年版). [5]Perez-Garcia et al. 2024 ASCO Annual Meeting (abstract number 1101).https://classic.clinicaltrials.gov/ct2/show/NCT05520723 ...
[2] NCCN.The NCCN clinical practice guidelines in oncology, breast cancer (version 4.2023)[EB/OL]. March 23, 2023. Accessed June 2023. Available at:https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf [3] G Curigliano, L Castelo-Branco, A Gennari,, et al. ESMO Metastatic ...
PubMed journal article: Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy. ...